Market closed· · GBp · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Cordiant Digital Infrastructure Ltd (LSE:CORD, FRA:86L) says booming AI demand is starting to convert into real contracted revenue. Quarterly revenue jumped over 20%, with a pipeline worth potentially over £1 billion. Digitalbox PLC (AIM:DBOX, FRA:RLXB) is pushing into original video with a growing creator network. It's aiming to hit around 500 videos a month by October as it responds to a turbulent first half. Zephyr Energy PLC (AIM:ZPHR, OTCQB:ZPHRF, FRA:VD5N) says second-quarter production from its non- operated US portfolio beat forecasts, up around 45% year on year. Its lender's also reaf
Digitalbox PLC (AIM:DBOX, FRA:RLXB) CEO James Carter spoke with Proactive's Stephen Gunnion about the company's new Creator Network strategy, aimed at accelerating video production, broadening audience reach and supporting future revenue growth. The initiative has already recruited around 200 creators across brands including The Tab, with Digitalbox targeting roughly 500 original videos a month as it diversifies beyond its traditional text-based publishing model. Carter said the expanded output will help the company engage audiences across more platforms and open up further direct advertising
Accesso Technology (LSE:ACSO, OTC:LOQPF, FRA:LQG) CEO Steve Brown says the acquisition of Dexibit is a step change in how the company delivers value to clients. He's targeting revenue growth of 7% to 9%, backed by AI, payments integration and cost efficiencies. Light Science Technologies (AIM:LST, FRA:9FD) CEO Simon Deacon says a new £300,000 glasshouse contract in Wales will act as a reference site for further growth across the UK and Europe. The company is positioning itself as a turnkey solutions provider in the AgTech sector. Poolbeg Pharma (AIM:POLB, OTC:POLBF, FRA:POLBF) has secured its
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.